Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: An immunohistochemical study with possible clinical relevance

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 85, Issue 4, 1998, Pages 438-443

  Hamakawa, Hiroyuki ^a   Bao, Yang ^a   Takarada, Manabu ^a   Fukuzumi, Masakuni ^a   Tanioka, Hiroaki ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN CYFRA21.1; COLORING AGENT; DIAGNOSTIC AGENT; KERATIN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; COMPARATIVE STUDY; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MAXILLA SINUS CANCER; MOUTH TUMOR; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ANTIBODIES; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; MAXILLARY SINUS NEOPLASMS; MOUTH NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032040193     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90070-1     Document Type: Article

References (28)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalogue of human cytokeratins: pattern of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Ebert W, Dienemann H, Fateh MA, Scheulen M, Konietzko N, Schleich T, et al. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuronspecific enolase in lung cancer: results of an international multicentre study. Eur J Clin Chem Clin Biochem 1994;32:189-99.
3. Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S. Assessment of serum CYFRA 21-1 in lung cancer. Cancer 1996;77:1274-7.
4. Inaba N, Negishi Y, Fukasawa I, Okajima Y, Ota Y, Tanaka K, et al. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinomarelated antigen. Tumour Biol 1995;16:345-52.
5. Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, et al. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer. Gynecol Oncol 1995;56:402-5.
6. Stieber P, Dienemann H, Hasholzner U, Fabricius PG, Schambeck C, Weinzierl M, et al. Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. Int J Biol Markers 1994;9:82-8.
7. Doweck I, Barak M, Greenberg E, Uri N, Kellner J, Lurie M, et al. CYFRA 21-1: a noble potential tumor marker for squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg 1995;121:177-81.
8. Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, FatehMoghadam A. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res 1996;16:3117-24.
9. Bartek J, Durban EM, Hallowes RC, Taylor-Papadimitriou J. A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins. J Cell Sci 1985;75:17-33.
10. Ivanyi D, Ansink A, Groeneveld E, Hageman PC, Mooi W J, Heintz APM. New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin-embedded tissue: keratin 10 expression in carcinoma of the vulva. J Pathol 1989;159:7-12.
11. Gown AM, Vogel AM. Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies. J Cell Biol 1982;95:414-24.
12. Moll R. Cytokeratine als differentierungsmarker: Expressions profile von Epithelien und Epithelialen Tumoren. Stuttgart: Gustav Fisher Verlag; 1993 p. 44-8.
13. Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983;48:372-94.
14. Jones JCR, Goldman AE, Yang HY, Goldman RD. The organizational fate of intermediate filament networks in two epithelial cell types during mitosis. J Cell Biol 1985;100:93-102.
15. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980;283:249-56.
16. Fey EG, Capco DG, Krochmalnic G, Penman S. Epithelial structure revealed by chemical dissection and unembedded electron microscopy. J Cell Biol 1984;99(suppl):203s-8s.
17. Fisher DZ, Chaudhary N, Blobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci U S A 1986;83:6450-4.
18. Sun TT, Tseng SC, Huang AJ, Cooper D, Schermer A, Lynch MH, et al. Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann N Y Acad Sci 1985;455:307-29.
19. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
20. Ogden GR, Lane EB, Hopwood DV, Chisholm DM. Evidence for field change in oral cancer based on cytokeratin expression. Br J Cancer 1993;67:1324-30.
21. Ogden GR, Chisholm DM, Adi M, Lane EB. Cytokeratin expression in oral cancer and its relationship to tumor differentiation. J Oral Pathol Med 1993;22:82-6.
22. Shi SR, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem 1995;43:193-201.
23. Imam SA, Young L, Chaiwun B, Taylor CR. Comparison of two microwave based antigen-retrieval solutions in unmasking epitopes in formalin-fixed tissue for immunostaining. Anticancer Res 1995;15:1153-8.
24. Berzinec P, Zuffova H, Letkovicova M, Arpasova M. Serum tumor marker CYFRA 21-1 in the diagnostics of squamous cell lung cancer: comparison with CEA. Neoplasma 1996;43:159-61.
25. Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer: evaluation of sensitivity, specificity, and prognostic role. Chest 1995;108:163-9.
26. Niklinski J, Furman M, Chyczewska E, Chyczewski L, Rogowski F, Laudanski J. Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer. Eur Respir J 1995;8:291-4.
27. Takada M, Masuda N, Matsuura E, Kusunoki Y, Matui K, Nakagawa K, et al. Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer 1995;71:160-5.
28. Koga H, Eguchi K, Shinkai T, Tamura T, Ohe Y, Oshita F, et al. Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients. Jpn J Clin Oncol 1994;24:263-8.